Assessment of hypnotic effects in the rat: Influence of the sleep-awake cycle
β Scribed by Dr. Leonard T. Meltzer; Kevin A. Serpa
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 463 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
β¦ Synopsis
The influence of the sleep-awake cycle of the rat on the apparent hypnotic effects of two benzodiazepine hypnotics, triazolam (short half-life) and flurazepam (long half-life), was assessed. Cortical electroencephalographic recordings from freely moving animals were used to determine whether the rats were awake or asleep. When tested during the dark phase of the light-dark cycle, when rats sleep approximately 50% of each hour, both agents increased sleep, with flurazepam having a longer duration of action than triazolam. In contrast, when tested during the light phase of the light-dark cycle, when rats sleep approximately 70-90% of each hour, the sleep-inducing effects of the two agents could not be distinguished. These data emphasize the importance of baseline levels of sleep in assessing hypnotic-drug effects.
π SIMILAR VOLUMES
Human activity is exerting an increasing influence on the hydrological cycle. In order to avoid adverse impacts and to establish optimum conditions for the water balance, it is necessary to understand the role of environmental parameters in influencing the hydrological cycle. Work is currently in pr
The effect of orally administered activated charcoal (AC) on the sleep times of mice following intravenous injection of various hypnotics was investigated. Preliminary studies with phenobarbital (Pb) showed that a linear relationship exists between the Pb-induced sleep time and the logarithm of the
## Abstract The Leeds sleep evaluation questionnaire (LSEQ) comprises ten selfβrating 100βmm line analogue questions concerned with sleep and early morning behaviour. A literature search identified 83 studies in peerβreviewed journals that reported the use of the LSEQ for psychopharmacological inve